Alabama
Colorectal cancer clinical trials in Alabama
17 colorectal cancer studies are recruiting participants at sites in 5 cities across Alabama as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Alabama city with a recruiting study
Birmingham (12), Mobile (5), Dothan (2), Homewood (1), Tuscaloosa (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Alabama
Basic details from each study's public record (the 12 most recently updated of 17). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Birmingham
- Registry record
- NCT07488676 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Recruiting in
- Mobile · Tuscaloosa
- Registry record
- NCT07228832 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Recruiting in
- Homewood
- Registry record
- NCT07446322 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Mobile
- Registry record
- NCT05174169 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Recruiting in
- Birmingham
- Registry record
- NCT07143487 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Recruiting in
- Birmingham
- Registry record
- NCT04657068 · updated
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
- No phase
- Ages 45 to 84
- All sexes
- Sponsor
- Jubaan Ltd.
- Recruiting in
- Dothan · Mobile
- Registry record
- NCT07623902 · updated
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Radiopharm Theranostics, Ltd
- Recruiting in
- Dothan
- Registry record
- NCT07189871 · updated
PRE-ISPY Phase I/II Oncology Platform Program
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- QuantumLeap Healthcare Collaborative
- Recruiting in
- Birmingham
- Registry record
- NCT05868226 · updated
DESTINY-PANTUMOUR04
- Observational
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Birmingham
- Registry record
- NCT07124000 · updated
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Guardant Health, Inc.
- Recruiting in
- Birmingham
- Registry record
- NCT05059444 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Recruiting in
- Birmingham
- Registry record
- NCT04851119 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Alabama on ClinicalTrials.gov.
Ask about studies in Alabama
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections